539730
FREDUN
Start SIP
Invest Now
Start SIP in FREDUN
Performance
- Low
- ₹1,818
- High
- ₹1,931
- 52 Week Low
- ₹635
- 52 Week High
- ₹1,999
- Open Price₹1,900
- Previous Close₹1,883
- Volume10,494
- 50 DMA₹1,620.33
- 100 DMA₹1,540.41
- 200 DMA₹1,351.21
Investment Returns
- Over 1 Month + 27%
- Over 3 Month + 6.71%
- Over 6 Month + 73.82%
- Over 1 Year + 151.24%
Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!
Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 25.3
- PEG Ratio
- 0.3
- Market Cap Cr
- 862
- P/B Ratio
- 5.5
- Average True Range
- 108.27
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 22.84
- RSI
- 66.76
- MFI
- 88.55
Fredun Pharmaceuticals Financials
Fredun Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,825.00
-57.5
(-3.05%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹1,655.65
- 50 Day
- ₹1,620.33
- 100 Day
- ₹1,540.41
- 200 Day
- ₹1,351.21
Resistance and Support
1858.35
- R3 2,011.70
- R2 1,971.35
- R1 1,898.70
- S1 1,785.70
- S2 1,745.35
- S3 1,672.70
Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-09 | Quarterly Results | |
| 2025-11-08 | Quarterly Results | |
| 2025-09-25 | Preferential Issue of shares & Others | To consider 1. Issue Of Warrants. alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method. |
| 2025-07-30 | Quarterly Results | |
| 2025-05-30 | Audited Results & Dividend |
Fredun Pharmaceuticals F&O
About Fredun Pharmaceuticals
- NSE Symbol
- FREDUN
- BSE Symbol
- 539730
- Managing Director & CFO
- Mr. Fredun Medhora
- ISIN
- INE194R01017
Similar Stocks to Fredun Pharmaceuticals
Fredun Pharmaceuticals FAQs
Fredun Pharmaceuticals share price is ₹1,825 As on 12 February, 2026 | 22:18
The Market Cap of Fredun Pharmaceuticals is ₹861.7 Cr As on 12 February, 2026 | 22:18
The P/E ratio of Fredun Pharmaceuticals is 25.3 As on 12 February, 2026 | 22:18
The PB ratio of Fredun Pharmaceuticals is 5.5 As on 12 February, 2026 | 22:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.